🇺🇸 FDA
Patent

US 8258324

Intermediates useful in the preparation of maleimide functionalized polymers

granted A61KA61K47/60

Quick answer

US patent 8258324 (Intermediates useful in the preparation of maleimide functionalized polymers) held by Nektar Therapeutics expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K47/60